ADRB2 and breast carcinoma: Both glucocorticoid and norepinephrine, through binding with their receptors, the glucocorticoid receptor (GR) and β2-adrenergic receptor (β2AR), respectively, facilitate breast-cancer metastasis through modulating various downstream-signaling pathways [4,6,7,8,9].